Is CCLD or MTLS more profitable?

CareCloud has a net margin of 7.87% compared to Materialise's net margin of 3.77%. CareCloud's return on equity of 24.05% beat Materialise's return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 7.87% 24.05% 16.38% Materialise 3.77% 4.05% 2.47%

Does the media refer more to CCLD or MTLS?

In the previous week, CareCloud and CareCloud both had 3 articles in the media. Materialise's average media sentiment score of 1.17 beat CareCloud's score of 0.62 indicating that Materialise is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareCloud 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Materialise 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate ECX or CCLD?

CareCloud has a consensus price target of $3.25, indicating a potential upside of 28.71%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than ECARX. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ECARX 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 CareCloud 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has preferable earnings and valuation, ECX or CCLD?

CareCloud has lower revenue, but higher earnings than ECARX. ECARX is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ECARX $847.90M 0.51 -$66.04M -$0.15 N/A CareCloud $120.50M 0.89 $10.80M $0.11 22.95

Is ECX or CCLD more profitable?

CareCloud has a net margin of 7.87% compared to ECARX's net margin of -6.23%. CareCloud's return on equity of 24.05% beat ECARX's return on equity. Company Net Margins Return on Equity Return on Assets ECARX -6.23% N/A -8.48% CareCloud 7.87% 24.05% 16.38%

Does the media prefer ECX or CCLD?

In the previous week, ECARX and ECARX both had 3 articles in the media. CareCloud's average media sentiment score of 0.62 beat ECARX's score of 0.30 indicating that CareCloud is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ECARX 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CareCloud 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate XNET or CCLD?

CareCloud has a consensus target price of $3.25, suggesting a potential upside of 28.71%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than Xunlei. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Xunlei 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 CareCloud 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33

Which has better earnings and valuation, XNET or CCLD?

Xunlei has higher revenue and earnings than CareCloud. Xunlei is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Xunlei $462.41M 0.81 $1.05B $13.67 0.43 CareCloud $120.50M 0.89 $10.80M $0.11 22.95

Is XNET or CCLD more profitable?

Xunlei has a net margin of 185.71% compared to CareCloud's net margin of 7.87%. CareCloud's return on equity of 24.05% beat Xunlei's return on equity. Company Net Margins Return on Equity Return on Assets Xunlei 185.71% 1.47% 1.24% CareCloud 7.87% 24.05% 16.38%

Does the media favor XNET or CCLD?

In the previous week, Xunlei had 4 more articles in the media than CareCloud. MarketBeat recorded 7 mentions for Xunlei and 3 mentions for CareCloud. CareCloud's average media sentiment score of 0.62 beat Xunlei's score of 0.57 indicating that CareCloud is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Xunlei 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive CareCloud 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is BLND or CCLD more profitable?

CareCloud has a net margin of 7.87% compared to Blend Labs' net margin of -3.72%. CareCloud's return on equity of 24.05% beat Blend Labs' return on equity. Company Net Margins Return on Equity Return on Assets Blend Labs -3.72% N/A -1.63% CareCloud 7.87% 24.05% 16.38%

Do analysts prefer CCLD or MIXT?

CareCloud presently has a consensus target price of $3.25, indicating a potential upside of 28.71%. Given CareCloud's stronger consensus rating and higher possible upside, equities analysts plainly believe CareCloud is more favorable than MiX Telematics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareCloud 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 MiX Telematics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is CCLD or MIXT more profitable?

CareCloud has a net margin of 7.87% compared to MiX Telematics' net margin of 3.72%. CareCloud's return on equity of 24.05% beat MiX Telematics' return on equity. Company Net Margins Return on Equity Return on Assets CareCloud 7.87% 24.05% 16.38% MiX Telematics 3.72% 8.45% 5.11%

CareCloud (CCLD) Competitors

$2.52 +0.18 (+7.45%)

As of 03:53 PM Eastern

Compare

CCLD vs. MTLS, ECX, XNET, BLND, and MIXT

Should you buy CareCloud stock or one of its competitors? MarketBeat compares CareCloud with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CareCloud include Materialise (MTLS), ECARX (ECX), Xunlei (XNET), Blend Labs (BLND), and MiX Telematics (MIXT). These companies are all part of the "computer software" industry.

How does CareCloud compare to Materialise?

CareCloud (NASDAQ:CCLD) and Materialise (NASDAQ:MTLS) are both small-cap computer software companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

10.2% of CareCloud shares are held by institutional investors. Comparatively, 19.3% of Materialise shares are held by institutional investors. 14.8% of CareCloud shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

CareCloud presently has a consensus price target of $3.25, indicating a potential upside of 28.71%. Materialise has a consensus price target of $10.00, indicating a potential upside of 45.48%. Given Materialise's higher probable upside, analysts clearly believe Materialise is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Materialise	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

CareCloud has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market. Comparatively, Materialise has a beta of 1.33, suggesting that its share price is 33% more volatile than the broader market.

CareCloud has higher earnings, but lower revenue than Materialise. CareCloud is trading at a lower price-to-earnings ratio than Materialise, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.89	$10.80M	$0.11	22.95
Materialise	$302.73M	1.34	$8.73M	$0.20	34.37

CareCloud has a net margin of 7.87% compared to Materialise's net margin of 3.77%. CareCloud's return on equity of 24.05% beat Materialise's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	7.87%	24.05%	16.38%
Materialise	3.77%	4.05%	2.47%

In the previous week, CareCloud and CareCloud both had 3 articles in the media. Materialise's average media sentiment score of 1.17 beat CareCloud's score of 0.62 indicating that Materialise is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareCloud	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Materialise	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Materialise beats CareCloud on 7 of the 13 factors compared between the two stocks.

How does CareCloud compare to ECARX?

ECARX (NASDAQ:ECX) and CareCloud (NASDAQ:CCLD) are both small-cap computer software companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

CareCloud has a net margin of 7.87% compared to ECARX's net margin of -6.23%. CareCloud's return on equity of 24.05% beat ECARX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ECARX	-6.23%	N/A	-8.48%
CareCloud	7.87%	24.05%	16.38%

In the previous week, ECARX and ECARX both had 3 articles in the media. CareCloud's average media sentiment score of 0.62 beat ECARX's score of 0.30 indicating that CareCloud is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ECARX	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CareCloud	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CareCloud has lower revenue, but higher earnings than ECARX. ECARX is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ECARX	$847.90M	0.51	-$66.04M	-$0.15	N/A
CareCloud	$120.50M	0.89	$10.80M	$0.11	22.95

CareCloud has a consensus price target of $3.25, indicating a potential upside of 28.71%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than ECARX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ECARX	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

10.2% of CareCloud shares are owned by institutional investors. 20.0% of ECARX shares are owned by insiders. Comparatively, 14.8% of CareCloud shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

ECARX has a beta of 1, suggesting that its stock price has a similar volatility profile to the broader market.Comparatively, CareCloud has a beta of 1.51, suggesting that its stock price is 51% more volatile than the broader market.

Summary

CareCloud beats ECARX on 13 of the 15 factors compared between the two stocks.

How does CareCloud compare to Xunlei?

Xunlei (NASDAQ:XNET) and CareCloud (NASDAQ:CCLD) are both small-cap computer software companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations.

Xunlei has a net margin of 185.71% compared to CareCloud's net margin of 7.87%. CareCloud's return on equity of 24.05% beat Xunlei's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Xunlei	185.71%	1.47%	1.24%
CareCloud	7.87%	24.05%	16.38%

In the previous week, Xunlei had 4 more articles in the media than CareCloud. MarketBeat recorded 7 mentions for Xunlei and 3 mentions for CareCloud. CareCloud's average media sentiment score of 0.62 beat Xunlei's score of 0.57 indicating that CareCloud is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Xunlei	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
CareCloud	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Xunlei has higher revenue and earnings than CareCloud. Xunlei is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xunlei	$462.41M	0.81	$1.05B	$13.67	0.43
CareCloud	$120.50M	0.89	$10.80M	$0.11	22.95

CareCloud has a consensus target price of $3.25, suggesting a potential upside of 28.71%. Given CareCloud's stronger consensus rating and higher probable upside, analysts plainly believe CareCloud is more favorable than Xunlei.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xunlei	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

Xunlei has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, suggesting that its share price is 51% more volatile than the broader market.

5.1% of Xunlei shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 21.7% of Xunlei shares are held by insiders. Comparatively, 14.8% of CareCloud shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

CareCloud beats Xunlei on 10 of the 16 factors compared between the two stocks.

How does CareCloud compare to Blend Labs?

Blend Labs (NYSE:BLND) and CareCloud (NASDAQ:CCLD) are both small-cap computer software companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

In the previous week, CareCloud had 2 more articles in the media than Blend Labs. MarketBeat recorded 3 mentions for CareCloud and 1 mentions for Blend Labs. CareCloud's average media sentiment score of 0.62 beat Blend Labs' score of 0.30 indicating that CareCloud is being referred to more favorably in the news media.

Company	Overall Sentiment
Blend Labs	Neutral
CareCloud	Positive

52.6% of Blend Labs shares are held by institutional investors. Comparatively, 10.2% of CareCloud shares are held by institutional investors. 40.3% of Blend Labs shares are held by insiders. Comparatively, 14.8% of CareCloud shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

CareCloud has lower revenue, but higher earnings than Blend Labs. Blend Labs is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Blend Labs	$123.51M	3.46	-$6.80M	-$0.10	N/A
CareCloud	$120.50M	0.89	$10.80M	$0.11	22.95

Blend Labs has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market. Comparatively, CareCloud has a beta of 1.51, meaning that its stock price is 51% more volatile than the broader market.

Blend Labs currently has a consensus target price of $3.32, suggesting a potential upside of 87.91%. CareCloud has a consensus target price of $3.25, suggesting a potential upside of 28.71%. Given Blend Labs' stronger consensus rating and higher possible upside, equities research analysts clearly believe Blend Labs is more favorable than CareCloud.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Blend Labs	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33

CareCloud has a net margin of 7.87% compared to Blend Labs' net margin of -3.72%. CareCloud's return on equity of 24.05% beat Blend Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Blend Labs	-3.72%	N/A	-1.63%
CareCloud	7.87%	24.05%	16.38%

Summary

CareCloud beats Blend Labs on 9 of the 16 factors compared between the two stocks.

How does CareCloud compare to MiX Telematics?

CareCloud (NASDAQ:CCLD) and MiX Telematics (NYSE:MIXT) are both small-cap computer software companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

CareCloud has a beta of 1.51, suggesting that its stock price is 51% more volatile than the broader market. Comparatively, MiX Telematics has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market.

CareCloud presently has a consensus target price of $3.25, indicating a potential upside of 28.71%. Given CareCloud's stronger consensus rating and higher possible upside, equities analysts plainly believe CareCloud is more favorable than MiX Telematics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareCloud	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
MiX Telematics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

CareCloud has a net margin of 7.87% compared to MiX Telematics' net margin of 3.72%. CareCloud's return on equity of 24.05% beat MiX Telematics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareCloud	7.87%	24.05%	16.38%
MiX Telematics	3.72%	8.45%	5.11%

In the previous week, CareCloud had 3 more articles in the media than MiX Telematics. MarketBeat recorded 3 mentions for CareCloud and 0 mentions for MiX Telematics. CareCloud's average media sentiment score of 0.62 beat MiX Telematics' score of 0.00 indicating that CareCloud is being referred to more favorably in the media.

Company	Overall Sentiment
CareCloud	Positive
MiX Telematics	Neutral

10.2% of CareCloud shares are owned by institutional investors. Comparatively, 45.7% of MiX Telematics shares are owned by institutional investors. 14.8% of CareCloud shares are owned by company insiders. Comparatively, 12.4% of MiX Telematics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

CareCloud has higher earnings, but lower revenue than MiX Telematics. CareCloud is trading at a lower price-to-earnings ratio than MiX Telematics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareCloud	$120.50M	0.89	$10.80M	$0.11	22.95
MiX Telematics	$150.06M	2.36	$4.52M	$0.25	58.20

Summary

CareCloud beats MiX Telematics on 11 of the 16 factors compared between the two stocks.

Get CareCloud News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CCLD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CCLD vs. The Competition

Export

Metric	CareCloud	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$107.29M	$1.62B	$6.32B	$12.64B
Dividend Yield	N/A	N/A	2.68%	5.31%
P/E Ratio	22.96	78.72	21.14	26.75
Price / Sales	0.89	6.87	548.19	115.38
Price / Cash	3.41	22.84	27.44	37.60
Price / Book	1.80	4.97	9.92	6.92
Net Income	$10.80M	-$54.76M	$3.56B	$336.84M
7 Day Performance	10.75%	3.71%	2.24%	4.33%
1 Month Performance	N/A	N/A	N/A	-0.37%
1 Year Performance	22.57%	1.52%	36.82%	40.73%

CareCloud Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CCLD CareCloud	3.5021 of 5 stars	$2.53 +7.4%	$3.25 +28.7%	+14.1%	$107.29M	$120.50M	22.96	3,650
MTLS Materialise	3.6703 of 5 stars	$6.19 +4.9%	$10.00 +61.6%	+24.4%	$365.64M	$302.73M	30.95	2,556	Positive News High Trading Volume
ECX ECARX	0.4637 of 5 stars	$1.02 +3.0%	N/A	-23.4%	$363.60M	$847.90M	N/A	1,432	Short Interest Increase
XNET Xunlei	1.5796 of 5 stars	$5.74 +4.7%	N/A	+5.9%	$360.76M	$462.41M	0.35	1,306
BLND Blend Labs	3.7425 of 5 stars	$1.48 +0.3%	$3.32 +124.9%	-51.4%	$357.13M	$123.51M	N/A	1,690	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CCLD) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareCloud (CCLD) Competitors

CCLD vs. MTLS, ECX, XNET, BLND, and MIXT

How does CareCloud compare to Materialise?

Summary

How does CareCloud compare to ECARX?

Summary

How does CareCloud compare to Xunlei?

Summary

How does CareCloud compare to Blend Labs?

Summary

How does CareCloud compare to MiX Telematics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCLD vs. The Competition

CareCloud Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CareCloud (CCLD) Competitors

CCLD vs. MTLS, ECX, XNET, BLND, and MIXT

How does CareCloud compare to Materialise?

Do insiders and institutionals have more ownership in CCLD or MTLS?

Do analysts recommend CCLD or MTLS?

Which has more volatility and risk, CCLD or MTLS?

Which has stronger valuation & earnings, CCLD or MTLS?

Is CCLD or MTLS more profitable?

Does the media refer more to CCLD or MTLS?

Summary

How does CareCloud compare to ECARX?

Is ECX or CCLD more profitable?

Does the media prefer ECX or CCLD?

Which has preferable earnings and valuation, ECX or CCLD?

Do analysts rate ECX or CCLD?

Do institutionals and insiders have more ownership in ECX or CCLD?

Which has more risk & volatility, ECX or CCLD?

Summary

How does CareCloud compare to Xunlei?

Is XNET or CCLD more profitable?

Does the media favor XNET or CCLD?

Which has better earnings and valuation, XNET or CCLD?

Do analysts rate XNET or CCLD?

Which has more risk and volatility, XNET or CCLD?

Do institutionals & insiders believe in XNET or CCLD?

Summary

How does CareCloud compare to Blend Labs?

Does the media favor BLND or CCLD?

Do institutionals & insiders hold more shares of BLND or CCLD?

Which has higher valuation & earnings, BLND or CCLD?

Which has more volatility and risk, BLND or CCLD?

Do analysts prefer BLND or CCLD?

Is BLND or CCLD more profitable?

Summary

How does CareCloud compare to MiX Telematics?

Which has more volatility & risk, CCLD or MIXT?

Do analysts prefer CCLD or MIXT?

Is CCLD or MIXT more profitable?

Does the media refer more to CCLD or MIXT?

Do institutionals and insiders believe in CCLD or MIXT?

Which has higher earnings & valuation, CCLD or MIXT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCLD vs. The Competition

CareCloud Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools